Exencial Wealth Advisors’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
Sell
-1,907
Closed -$61K 174
2016
Q4
$61K Buy
+1,907
New +$61K 0.03% 167